Scientists are starting to accumulate huge datasets on which genes mutate during cancer, allowing for a more systematic approach to "precision medicine." In a study publishing in Cell, researchers compared genetic mutations in patient tumors to those in cancer cell lines and then tested the cell lines' responses to therapeutic compounds. By analyzing where these datasets overlap, researchers can begin to predict on a large scale which drugs will best fight various cancers.
"The process that we've done, by nature, is a discovery process," says the author. "It's the beginning of generating exciting new ideas about how we might target specific patient populations with specific drugs. This type of study wasn't possible a few years ago because we hadn't sequenced enough patient tumors."
When developing new anti-cancer drugs, researchers often rely first on cancer cell lines in the lab. "You can't screen hundreds of drugs across a single patient. It's not possible," says another author. "But you can do that with cell lines--you can expose them to many different drugs and ask questions about which is more or less sensitive."
How closely these cell lines match what actually happens in a human tumor has been unclear, however, and previous efforts to model drug response using cancer cell lines were done on a relatively small scale. To investigate a larger piece of the landscape, researchers analyzed data from two public datasets, The Cancer Genome Atlas and the International Cancer Genome Consortium, and other studies, gathering genetic information for more than 11,000 tumor samples.
The team then compared these tumor samples to about 1,000 cancer cell lines used in labs, looking for lines that had the same types of mutations as the patient samples--and therefore might more closely mimic patient responses. "Many of the cell lines do capture the molecular features that are important to human beings in cancer," says the author.
Once they mapped the tumor mutations onto the cell lines, the researchers looked for the genetic mutations that could best predict the cancer cells' response to 265 different anti-cancer compounds at various stages of development. The drugs covered a range of mechanisms, including chemotherapeutics, small-molecule inhibitors, epigenetic modulators, and cell death regulators.
Many of the mutations that occurred both in tumor samples and cell lines did signal whether the cancer cells would be sensitive or resistant to different compounds, largely depending on the type of tissue the cancer originated in. "If you can identify the clinically relevant features in cell lines and correlate those with drug response, you're one step closer to identifying a drug interaction that could be important for a patient," says the author.
"We've taken a leap forward in doing this type of study in a very comprehensive and systematic way, as opposed to what often is done, where someone might do it with a single drug or in a single cell line," explains another author. "It's by no means the end of the journey--but it's a huge milestone."
Going forward, the researchers are creating a web portal to share their data, which will allow cancer researchers to see which cell lines most closely mirror the patient condition they aim to emulate and how those cell lines respond to different drugs. The teams are also starting their own follow-up projects to investigate associations between certain cell mutations and drug effects, with the hope of more clearly pinpointing which cancer patients will most benefit from a given compound.
http://www.cell.com/cell/fulltext/S0092-8674(16)30746-2
Latest News
Key mechanism for maintaini…
By newseditor
Posted 06 Jun
How tumor stiffness alters…
By newseditor
Posted 06 Jun
Neural circuit involved in…
By newseditor
Posted 06 Jun
Signaling mechanism in live…
By newseditor
Posted 05 Jun
Statin prevents cancer deve…
By newseditor
Posted 05 Jun
Other Top Stories
Stuttering Linked to Reduced Blood Flow in Area of Brain Associated…
Read more
Brain circuit for body temperature control
Read more
Brain protein predicts recovery time following concussion
Read more
Linking gestational diabetes mellitus (GDM) to short sleep during p…
Read more
Neurons Modulate the Growth of Blood Vessels
Read more
Protocols
Clinical and CSF single-cel…
By newseditor
Posted 05 Jun
ChatGPT-assisted deep learn…
By newseditor
Posted 04 Jun
Turning the tide in aggress…
By newseditor
Posted 03 Jun
Mapping medically relevant…
By newseditor
Posted 01 Jun
Accessible high-speed image…
By newseditor
Posted 30 May
Publications
Aggregation-resistant alpha…
By newseditor
Posted 06 Jun
POT1 recruits and regulates…
By newseditor
Posted 06 Jun
Normal or improved cardiova…
By newseditor
Posted 06 Jun
Cytosolic pH is a direct ne…
By newseditor
Posted 06 Jun
Control of feeding by a bot…
By newseditor
Posted 06 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar